The Australia fertility services market size reached USD 1,038.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,889.2 Million by 2034, exhibiting a growth rate (CAGR) of 11.68% during 2026–2034. Rising demand driven by delayed parenthood, increased infertility diagnoses, broader awareness, technological advances like genetic screening, and growing adoption of fertility preservation are highlighting the sector's momentum. These drivers, combined with expanding accessibility and supportive healthcare initiatives, are among the key factors contributing to the Australia fertility services market share.

Australia's fertility services sector is experiencing a structural expansion driven by intersecting demographic, social, and policy forces — with delayed family formation trends across Australia's professional population, increasing incidence of diagnosed infertility in both male and female cohorts, and growing social acceptance of assisted reproductive technology collectively expanding the patient population seeking fertility treatment. The March 2025 Australian Government expansion of Pharmaceutical Benefits Scheme listings — including Slinda (progestogen-only contraceptive), Ryeqo (endometriosis treatment), and broader access to Pergoveris (IVF hormone therapy) — is materially reducing cost barriers that previously prevented earlier intervention and treatment access. Victoria's public fertility program, which marked a milestone in April 2025 with over 150 babies born through Australia's first free public IVF service — operating through satellite clinics across regional areas and supported by Australia's first public egg and sperm bank at the Royal Women's Hospital — signals a nationwide shift toward public provision that is broadening the addressable fertility services market beyond the privately insured patient cohort that has historically dominated clinical volumes. IVF with intracytoplasmic sperm injection (ICSI) leads procedure demand, reflecting the growing prevalence of complex infertility cases requiring advanced embryological intervention, while egg and embryo banking services are growing rapidly as fertility preservation becomes a proactive reproductive health management strategy for Australians across a wider age and lifestyle demographic.

Evaluate Market Potential Before You Invest – Get the Report Sample

[URL=https://www.imarcgroup.com/australia-fertility-services-market/requestsamplehttps://www.imarcgroup.com/australia-fertility-services-market/requestsample[/URL]

How AI is Reshaping the Future of the Australia Fertility Services Market

• AI-powered embryo selection algorithms are enabling Australian IVF laboratories to identify the highest-viability embryos for transfer through image-based morphological analysis and time-lapse incubation monitoring — improving clinical pregnancy rates, reducing the number of cycles required to achieve successful outcomes, and lowering the per-pregnancy cost of IVF treatment in ways that improve accessibility for patients managing the financial burden of multiple treatment cycles.